Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Vikas Life Press Note

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

January 16, 2023

Listing Compliance Department Listing Compliance Department


National Stock Exchange of India Limited. BSE Limited.
Exchange Plaza, Bandra-Kurla Complex, Phirozee Jeejeebhoy Towers,
Bandra (E), Mumbai 400051 Dalal Street, Fort,
Fax: 022-26598235/36 Mumbai - 400 001

NSE Symbol: VIKASLIFE Scrip Code: 542655

Sub: Media Release


DSIR Recognition to Vikas Lifecare’s In-House R&D Unit(s)

Dear Sir/ Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements)


Regulations, 2015, please find enclosed herewith copy of Media Release titled DSIR
Recognition to Vikas Lifecare’s In-House R&D Unit(s)

We request you to kindly take the above information on record and oblige.

Thanking you,

Yours Faithfully,
for Vikas Lifecare Limited
SUNDEEP Digitally signed
KUMAR by SUNDEEP
DHAWAN KUMAR DHAWAN

Sundeep Kumar Dhawan


Managing Director
DIN: 09508137
MEDIA RELEASE

DSIR Recognition to Vikas Lifecare’s In-House R&D Unit(s)

January 16, 2023, New Delhi: Vikas Lifecare Limited is pleased to inform that Company’s In-House R&D
Unit(s) has recently got recognition from Department of Scientific and Industrial Research, Ministry of
Science & Technology, Government of India (DSIR). This prestigious DSIR recognition set-up by
Government of India for benchmarking of the industrial R&D not only acknowledges company’s In-House
R&D activities’ supremacy, par excellence research work and innovations, but also encourages us to
maintain our R&D activities at par with international standards.

This DSIR recogination for Company In-house R&D Units make it eligible for receiving funds for R&D
purpose from various government departments and agencies, and enable us to invest further into necessary
equipments with reduced or zero tax liability, as R&D Equipments could now be imported with 100% custom
duty exemption whereas domestic equipment purchases ’ll attract reduced GST rate of 5% only. Further, in
case a product arising out of the R&D unit is patented in India and one more from other country (the US,
China, or EU), the product can be sold without any excise duty for a period of three years.

The recognition and the pursuing benefits will help VLL generate additional revenues via manufacturing
niche materials and or sales of the in house technology to produce such materials and or roralty fee generated
from the technology / technique is let out to other producers of similar materials.

About Vikas Lifecare Limited:

Vikas Lifecare Ltd. (VLL) is an ISO 9001:2015 certified company, historically engaged in the business of
manufacturing of Polymer and Rubber compounds and Specialty Additives for Plastics, Synthetic &Natural
Rubbers. The company has been conventionally engaged in various business segments including Polymer &
Rubber Commodity (bulk consumption) Compounds and Master-Batches. Manufacturing Up-Cycled
Compounds from industrial and post-consumer waste and scrap materials like EVA, PVC, PP, PE etc.,
directly contributing to the Environment Protection initiatives from the Government of India and fulfilling
the mandated EPR obligations for the conglomerates using hundreds of thousands of tons of plastic products
and packaging materials. VLL is also a Del-Credere agent of ONGC– The Oil and Natural Gas Corporation
Ltd.” Petro Additions Limited, a public sector undertaking producing a wide variety of base polymers and
commodity plastic raw materials. VLL has a division engaged in Agro Products Business, The Company is
empaneled with NAFED – The “National Agricultural Co-Operative Federation of India” and HOFED –
The “Uttar Pradesh Horticultural Co-Operative Marketing Federation”. As a long-term business strategy, the
company has most recently diversified its business interests beyond raw materials (B2B businesses) and
forayed into the B2C segment with a host of consumer products for FMCG, Agro, and Infrastructure
Segments; paving way for an aggressive business growth with adding intricately planned and selected
product portfolios via acquisitions, joint ventures and tie-ups. VLL intends establishing / acquiring
businesses in diverse segments thereby expanding its business stakes and a footprint across the country and
beyond.

The securities of the Company are listed on both the Stock Exchanges, BSE (Scrip Code: 542655) and NSE
(Scrip Code: VIKASLIFE).

Disclaimer: Certain statements, words in this document that are not historical facts are forward looking statements. Such
forward looking statements are subject to certain risks and uncertainties like government actions, local, political or economic
developments, technological risks and many other factors that could cause actual result to differ materially from those
contemplated by these forward-looking statements. Vikas Lifecare Limited shall not be in any way responsible for any action
taken based on such statements.

You might also like